The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 11, 2012, Pages 1185-1191

  Lazaros, Leandros A ^a   Hatzi, Elissavet G ^a   Pamporaki, Christina E ^a   Sakaloglou, Prodromos I ^a   Xita, Nectaria V ^a   Markoula, Sophia I ^a   Stefos, Theodoros I ^a   Zikopoulos, Konstantinos A ^a   Georgiou, Ioannis A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Controlled ovarian stimulation; CYP19; FSHR; IVF; SHBG

Indexed keywords

AROMATASE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HORMONE BINDING PROTEIN; LUTEINIZING HORMONE;

ADULT; ALLELE; ARTICLE; CELL COUNT; CHILDBIRTH; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HORMONAL THERAPY; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY STIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AROMATASE; FEMALE; FERTILIZATION IN VITRO; GENOTYPE; GONADOTROPINS; HUMANS; OOCYTE RETRIEVAL; OVARIAN FOLLICLE; OVARY; OVULATION INDUCTION; POLYMORPHISM, GENETIC; RECEPTORS, FSH; SEX HORMONE-BINDING GLOBULIN; SPERM INJECTIONS, INTRACYTOPLASMIC;

MAMMALIA;

EID: 84878371127     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9849-0     Document Type: Article

References (42)

1. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of pituitary gonadotropins. Endocr Rev. 1990;11:177-99.
2. Simoni M, Nieschlag E. FSH in therapy: physiological basis, new preparations and clinical use. Reprod Med Rev. 1995;4:163-7.
3. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997;18:739-73.
4. Misao R, Nakanishi Y, Fujimoto J, Tamaya T. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects. Gyn Endocrinol. 1995;9:317-23.
5. Forges T, Gerard A, Hess K, Monnier-Barbarino P, Gerard H. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells. Mol Cell Endocrinol. 2004;219:61-8.
6. Hammond GL, Bocchinfuso WP. Sex hormone-binding globulin/androgen-binding protein: steroid-binding and dimerization domains. J Ster Biochem Mol Biol. 1995;53:543-52.
7. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15:342-55.
8. Simoni M, Gromoll J, Hoppner W, Kamischke A, Kraft T, Stahle D, et al. Mutational analysis of the follicle-stimulating hormone receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab. 1999;84:751-5.
9. n repeat element within an Alu sequence. J Biol Chem. 2001;276:36383-90.
10. Xita N, Lazaros L, Georgiou I, Tsatsoulis A. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype. Fertil Steril. 2010;94:250-4.
11. n polymorphism with follicle size in women undergoing ovarian stimulation. Gynecol Endocrinol. 2011;27:27-32.
12. Lazaros L, Hatzi E, Xita N, Makrydimas G, Kaponis A, Takenaka A, et al. Aromatase (CYP19) gene variants influence ovarian response to standard gonadotrophin stimulation. J Assist Reprod Genet. 2012;29:203-9.
13. Lazaros L, Hatzi E, Xita N, Makrydimas G, Kaponis A, Plachouras N, Sofikitis N, Stefos T, Zikopoulos K, Georgiou I. Ovarian response to standard gonadotrophin stimulation for IVF/ICSI is influenced by FSHR diplotypes. 2012 J Reprod Med (in press).
14. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, et al. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril. 1989;51:292-7.
15. Lazaros L, Xita N, Kaponis A, Zikopoulos K, Sofikitis N, Georgiou I. Evidence for association of Sex hormone-binding globulin and androgen receptor genes with semen quality. Andrologia. 2008;40:186-91.
16. Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Eur J Endocrinol. 2008;158:861-5.
17. Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G, et al. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res. 2003;11:578-85.
18. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulose cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab. 1979;49:851-60.
19. Nayudu PL, Lapota A, Jones GM, Gook DA, Bourne HM, Sheather SJ, et al. An analysis of human oocytes and follicles from stimulated cycles: oocyte morphology and associated follicular fluid characteristics. Hum Reprod. 1989;4:558-67.
20. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM. The effect of a null mutation in the FSH receptor gene on mouse reproduction. Endocrinology. 2000;141:1795-803.
21. Abel MH, Huhtaniemi I, Pakarinen P, Kumar TR, Charlton HM. Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSH subunit knockout mice. Reproduction. 2003;125:165-73.
22. Hirst RC, Abel MH, Wilkins V, Simpson C, Knight PG, Zhang F, et al. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary. Reproduction. 2004;128:43-52.
23. de Castro F, Ruiz R, Montoro L, Pérez-Hernández D, Sánchez-Casas Padilla E, Real LM, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003;80:571-6.
24. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet. 2006;51:665-70.
25. Livshyts G, Podlesnaja S, Kravchenko S, Sudoma I, Livshits L. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine. J Assist Reprod Genet. 2009;26:29-34.
26. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365-9.
27. Théron-Gérard L, Pasquier M, Czernichow C, Cédrin-Durnerin I, Hugues JN. Follicle-stimulating hormone receptor polymorphism and ovarian function. Gynecol Obstet Fertil. 2007;35:135-41.
28. Wunsch A, Ahda Y, Banaz-Yaşar F, Sonntag B, Nieschlag E, Simoni M, et al. Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris). 2007;68:160-6.
29. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, et al. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril. 2003;80:986-99.
30. Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J Clin Endocrinol Metab. 2003;88:5976-80.
31. Cousin P, Calemard-Michel L, Lejeune H, Raverot G, Yessaad N, Emptoz-Bonneton A, et al. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. J Clin Endocrinol Metab. 2004;89:917-24.
32. n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome. Hum Reprod. 2007;22:1031-6.
33. Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, et al. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod. 1996;11:1387-92.
34. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622-9.
35. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metabol. 1991;72:560-6.
36. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metabol. 1994;78:1287-92.
37. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metabol. 1995;80:3689-98.
38. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, et al. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metabol. 2007;92:982-90.
39. Altmäe S, Haller K, Peters M, Saare M, Hovatta O, Stavreus-Evers A, et al. Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report. Reprod Biomed Online. 2009;18:651-7.
40. Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG, et al. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Letters. 2004;207:191-6.
41. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77-83.
42. Seifer DB, Maclaughlin DT. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007;88:539-46.